LPCN
LPCN
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
2
$107K
Insider Sales
0
$0
Total Volume
$107K
2 transactions
Net Activity
+$107K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Patel Mahesh V.
CEO
$79K total
Higuchi John W.
Dir
$27K total
Quick Actions
LPCN has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. LPCN ranks #487 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at LPCN (LPCN) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $107K.
The net insider activity for LPCN shows a net buying bias of $107K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Patel Mahesh V. (CEO), who traded 50.0K shares valued at $79K on Nov 12, 2026.
Lipocine Inc. (LPCN) stock price, news, quote and history
Lipocine Stock Price Forecast. Should You Buy LPCN?
LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today
LPCN Stock Pops As BLOOM Phase 3 Trial Kicks Off
LPCN Stock Jumps As BLOOM Phase 3 Trial Kicks Off
LPCN - Lipocine Inc Stock Price and Quote
FAQs About LPCN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for LPCN.